Many parents of kids who need insulin have to caution their children from a young age to make life decisions based on affording their insulin including choosing their careers due to insurance coverage.
Patients For Affordable Drugs Responds To The Industry’s $18 Million Attack Ads Aimed At Thwarting Reforms To Lower Drug Prices
Right now, Big Pharma is bankrolling an ad campaign worth tens of millions of dollars against the reforms that would allow Medicare to negotiate lower drug prices.
To keep advocating for others, I need to afford my medications. But with prices so high, there are no guarantees I’ll be able to afford the medicine I need to live.
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
Take a look at this year's price hikes to see why Congress must act now.
P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
